stockrowAkebia Therapeutics, Inc. (AKBA) vs Lifecore Biomedical, Inc. (LFCR)
- Akebia Therapeutics, Inc. AKBA 0.43 −37.68%
- Lifecore Biomedical, Inc. LFCR 6.39 −0.78%
Akebia Therapeutics, Inc. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $242.6M against $117.9M — 2.1× the size. Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: −12.4% against −18.2%. Akebia Therapeutics, Inc. has the higher net margin (−22.6% vs −65.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Akebia Therapeutics, Inc. leads on 9 and Lifecore Biomedical, Inc. on 8.
Valuation
Profitability
| Metric | AKBA | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 78.90% | 27.38% | 53.51% |
| Operating margin | (15.74%) | (5.33%) | 0.00% |
| Net margin | (22.60%) | (65.91%) | (2.45%) |
| Free cash flow margin | 7.03% | 9.86% | 0.00% |
| Return on equity | (143.83%) | 178.69% | (0.80%) |
| Return on assets | (12.62%) | (32.36%) | (1.67%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack